Medpace 

M$6,890
-M$765-9.99% Friday 15:19

統計

當日最高
6,890
當日最低
6,890
52週最高
7,655
52週最低
4,158
成交量
0
平均成交量
0
市值
133.17B
市盈率
33.63
股息收益率
-
股息
-

即將到來

收益

21Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
1.8
2.27
2.73
3.2
預期每股收益
2.770639
實際每股收益
3.01

人們還關注

此列表基於在 Stock Events 上關注 MEDP.MX 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
首席執行官
Dr. August James Troendle M.D.
員工
5000
國家
United States
ISIN
US58506Q1094

上市公司